IDEAS home Printed from https://ideas.repec.org/p/boc/scon14/2.html
   My bibliography  Save this paper

Optimal Interval Design for Phase I Oncology Clinical Trials

Author

Listed:
  • Bryan Fellman

    (MD Anderson Cancer Center)

  • Ying Yuan

    (MD Anderson Cancer Center)

Abstract

The optimal interval design is a novel phase I trial design for finding the maximum tolerated dose (MTD). The optimal interval design casts dose finding as a sequential decision making problem for assigning an appropriate dose for each enrolled patient. The design optimizes the assignment of doses to patients by minimizing incorrect decisions of dose escalation/deescalation, i.e., erroneously escalating (or deescalating) the dose when the current dose is actually higher (or lower) than the MTD. This feature of the optimal interval design strongly ensures adherence to ethical standards. In addition, as the optimal dose assignment tends to treat patients at (or close to) the MTD, at the end of the trial, this design will be able to select the MTD with a high probability because most data and statistical power are concentrated around the MTD. This presentation will briefly cover the methods of the design and demonstrate a command that implements them in a clinical setting.

Suggested Citation

  • Bryan Fellman & Ying Yuan, 2014. "Optimal Interval Design for Phase I Oncology Clinical Trials," 2014 Stata Conference 2, Stata Users Group.
  • Handle: RePEc:boc:scon14:2
    as

    Download full text from publisher

    File URL: http://repec.org/bos2014/boston14_fellman.pdf
    Download Restriction: no
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:boc:scon14:2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Christopher F Baum (email available below). General contact details of provider: https://edirc.repec.org/data/stataea.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.